Differences in Biological Activity Between PACAP27 and VIP in PC12 Cells Depend on Their N-Terminal Structures

Author： Onoue Satomi Nagano Yumiko Endo Kosuke Yajima Takehiko Kashimoto Kazuhisa

ISSN： 1060-4456

Source： Pharmacology Communications, Vol.12, Iss.4, 2002-10, pp. : 205-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Neuropeptides VIP / PACAP and T Cells: Inhibitors or Activators?

Current Pharmaceutical Design, Vol. 9, Iss. 12, 2003-05 ,pp. : 997-1004

Bentham Science Publishers

Access to resources Recommend Favorite

Interactions of VIP, Secretin and PACAP1-38 with Phospholipids: A Biological Paradox Revisited

Current Pharmaceutical Design, Vol. 9, Iss. 12, 2003-05 ,pp. : 1005-1012

Bentham Science Publishers

Access to resources Recommend Favorite

PEGylation of Octreotide: II. Effect of N-terminal Mono-PEGylation on Biological Activity and Pharmacokinetics

By Na Dong Hee Lee Kang Choon DeLuca Patrick P.

Pharmaceutical Research, Vol. 22, Iss. 5, 2005-05 ,pp. : 743-749

Springer Publishing Company

Access to resources Recommend Favorite

VIP and PACAP in pain and inflammation

By Said S.I.S.I.

Trends in Pharmacological Sciences, Vol. 21, Iss. 2, 2000-02 ,pp. : 57-57

Elsevier

Access to resources Recommend Favorite

VIP and PACAP: very important in pain?

By Dickinson T. Fleetwood-Walker S.M.

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 324-329

Elsevier

Access to resources Recommend Favorite